نتایج جستجو برای: targeted peptide

تعداد نتایج: 304789  

Journal: :journal of current ophthalmology 0
xiaohong liu bingqian liu huiling hu ying liu fei deng jian ge

purpose : to investigate the effects of mtp-131 on trabeculum cells cultured under hydrostatic pressure methods : glaucomatous human trabecular meshwork (gtm3) cells were divided into three groups: the mtp-131 group, the hydrostatic group, and the normal group. the mtp-131 group was pretreated with 1 µm mtp-131, and the cells were then cultured under 80 mmhg pressure for 24 hours. the normal gr...

Objective(s): Somatostatin receptor-positive neuroendocrine tumors have been targeted using various peptide analogs radiolabeled with therapeutic radionuclides for years. The better biomedical properties of radioantagonists as higher tumor uptake make these radioligands more attractive than agonists for somatostatin receptor-targeted radionuclide therapy. In this study...

Journal: :the iranian journal of pharmaceutical research 0
bahram kazemi shahid beheshti university of medical sciences amir zarebkohan biomedical engineering and medical physics department, faculty of medicine, shahid beheshti university of medical sciences, tehran, iran farhood najafi department of resin and additives, institute for color science and technology, tehran, iran hamid reza moghimi school of pharmacy, shahid beheshti university of medical sciences, tehran, iran mohammad hemmati biomedical engineering and medical physics department, faculty of medicine, shahid beheshti university of medical sciences, tehran, iran mohammad reza deevband biomedical engineering and medical physics department, faculty of medicine, shahid beheshti university of medical sciences, tehran, iran

glioma, as a primary tumor of central nervous system, is the main cause of death in patients with brain cancer. therefore, development of an efficient strategy for treatment of glioma is worthy. the aim of the current study was to develop a srl peptide-coated dendrimer as a novel dual gene delivery system for targeting the lrp receptor, an up-regulated gene in both bbb and glioma cells. to perf...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006
Marta Cremonesi Mahila Ferrari Lisa Bodei Giampiero Tosi Giovanni Paganelli

The potential of targeted therapy with radiolabeled peptides has been reported in several clinical trials. Although there have been many improvements in dose estimation, a general and reliable dosimetric approach in peptide receptor radionuclide therapy (PRRT) is still a matter of debate. This article reviews the methods for PRRT dosimetry and the results presented in the literature. Radiopharm...

Mahmoud Omidi, Mostafa Erfani, Nourollah sadeghzadeh,

Background: Bombesin shows high affinity for Gastrin-releasing peptide (GRP) receptors which over expressed on the cell surfaces of several human tumors particularly in prostate and breast cancers. The aim of this study was labeling of designed analogue with99mTc via HYNIC and Tricine /EDDA and evaluation as potential targeted tumor scintigraphic agent. Materials and Methods: HYNIC-Bombesin wa...

Journal: :research in molecular medicine 0
nourollah sadeghzadeh department of radiopharmacy, faculty of pharmacy, mazandaran university of medical sciences, sari, iran. mostafa erfani 2nuclear science research school, nuclear science & technology research institute (nstri), atomic energy organization of iran, tehran, iran mahmoud omidi 3department of toxicology, faculty of pharmacy, mazandaran university of medical sciences, sari, iran

background: bombesin shows high affinity for gastrin-releasing peptide (grp) receptors which over expressed on the cell surfaces of several human tumors particularly in prostate and breast cancers. the aim of this study was labeling of designed analogue with99mtc via hynic and tricine /edda and evaluation as potential targeted tumor scintigraphic agent.materials and methods: hynic-bombesin was ...

Tumor-targeted therapies are playing growing roles in cancer research. The exploitation of these powerful therapeutic modalities largely depends on the discovery of tumor-targeting ligands. Phage display has proven a promising high throughput screening tool for the identification of novel specific peptides with high binding affinity to cancer cells. In the present study, we describe the use of ...

Tumor-targeted therapies are playing growing roles in cancer research. The exploitation of these powerful therapeutic modalities largely depends on the discovery of tumor-targeting ligands. Phage display has proven a promising high throughput screening tool for the identification of novel specific peptides with high binding affinity to cancer cells. In the present study, we describe the use of ...

Journal: :Physiological Research 2016

Journal: :reports of biochemistry and molecular biology 0
farideh hosseinzadeh shiraz hiv/aids research center, shiraz university of medical sciences, shiraz, iran-recombinant antibody laboratory, department of immunology, shiraz university of medical sciences, shiraz, iran s. saeed mohammadi shiraz hiv/aids research center, shiraz university of medical sciences, shiraz, iran-recombinant antibody laboratory, department of immunology, shiraz university of medical sciences, shiraz, iran foroogh nejatollahi tel: +98 71 32351575; fax: +98 71 32351575

background:  cytotoxic t lymphocyte–associated antigen 4 (ctla-4) molecules are expressed on t-cells and inhibit their function by inhibiting activation of subsequent t-cell molecular pathways. blocking of ctla-4 inhibits the growth of malignant tumor cells. anti-ctla-4 monoclonal antibodies activate the immune system against cancer. due to several advantages of single-chain antibodies (scfvs) ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید